Saturday 17 October 2026 Export AMWL’s income statement to Excel — free account

American Well Corporation

AMWL Healthcare Health Information Services

American Well Corporation’s revenue for fiscal 2025 (year ended December 2025) was $249.3 million, down 1.98% from fiscal 2024. In the quarter to June 2026, revenue fell 26.6%, EPS grew 52.4% and free cash flow grew 266.4%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

11.68 0.70 −5.65%

Follow AMWL

Alert me

Market cap: $210.6M
P/E: 0.0×
Fwd P/E: −2.6×
Dividend yield: —
F-score: 6/9
Altman Z: −7.95
Beneish M: −3.29
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.00

Total sells 1.05

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	1	—	—	—	—	—
Sell	—	3	3	—	4	3	—	4	4	—	3	4

Insider Ownership 17.84%

Capital & Financial Ratios $m

Market Cap 210.57

Revenue 218.53

Net Income (77.01)

Free Cash Flow (32.04)

Net Debt (196.74)

Current Ratio 2.90

Debt/Equity 0.00

P/E ratio 0.00

Fwd P/E (2.64)

P/S ratio 0.90

P/B ratio 0.84

Past 5Y EPS Growth —

This Y EPS Growth 56.96%

Next Y EPS Growth 18.18%

Next Y revenue growth (18.54%)

Next 5Y EPS Growth 38.59%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 38.64%

10-year low 10-year high

P/B against its own 10 years 56.95%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	372	228	182	197
Receivables	54	72	50	53
Inventory	7	3	1	1
Other	—	—	—	—
	450	317	247	265

	2023	2024	2025	Q'26
Payables	5	5	2	2
ST’ Debt	—	—	—	—
Other	—	—	—	—
	94	111	73	91

Compound Annual Growth %

	10y	5y	3y
Sales	—	0.33%	(3.47%)
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	(27.61%)	(38.85%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	55	52	—	—	—
’25	67	71	56	55	249
’24	60	63	61	71	254
’23	64	62	62	71	259
’22	64	65	69	79	277
’21	58	60	62	73	253
’20	54	69	63	60	245

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(1)	11	—	—	—
’25	(25)	(5)	(19)	(17)	(66)
’24	(60)	(22)	(32)	(13)	(127)
’23	(29)	(40)	(38)	(42)	(148)
’22	(62)	(43)	(51)	(36)	(192)
’21	(41)	(26)	(29)	(45)	(142)
’20	(32)	(26)	(30)	(25)	(112)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(4)	8	—	—	—
’25	(25)	(5)	(19)	(17)	(66)
’24	(63)	(27)	(37)	(16)	(143)
’23	(36)	(47)	(38)	(43)	(164)
’22	(62)	(43)	(51)	(46)	(203)
’21	(41)	(26)	(29)	(45)	(142)
’20	(33)	(27)	(31)	(25)	(116)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.66)	(0.59)	—	—	—
’25	(1.19)	(1.24)	(2.00)	(1.52)	(5.96)
’24	(5.00)	(3.36)	(2.87)	(2.77)	(13.88)
’23	(28.40)	(6.60)	(9.60)	(3.40)	(47.60)
’22	(5.20)	(5.00)	(5.00)	(4.40)	(19.80)
’21	(3.20)	(3.00)	(4.00)	(3.60)	(13.80)
’20	(11.90)	(40.58)	(18.40)	25.17	(45.40)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	426.80	113.40	50.40	18.50	5.00	3.71	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	836.00	875.00	126.00	85.50	31.20	12.95
People
People	Employees	—	—	—	686	812	1,035	1,035	1,104	877	562
	Revenue/emp, $m	—	—	0.00	0.22	0.30	0.24	0.27	0.23	0.29	0.44
Income, $m
Income, $m	Revenue	—	—	114	149	245	253	277	259	254	249
	Gross margin, %	—	—	48.57	46.27	36.07	41.27	42.13	36.58	38.90	53.29
	EBT	—	—	(52)	(89)	(226)	(179)	(270)	(673)	(207)	(93)
	EBT margin, %	—	—	(45.91)	(59.90)	(92.06)	(70.82)	(97.31)	(259.69)	(81.29)	(37.24)
	Net income	—	0	(52)	(88)	(229)	(177)	(272)	(679)	(213)	(95)
	Depreciation	—	—	7	10	12	19	28	471	36	38
Per share, $
Per share, $	Revenue	—	—	56.16	72.37	49.53	19.90	20.22	18.23	16.96	15.54
	Earnings	—	—	(25.78)	(42.96)	(45.40)	(13.80)	(19.80)	(47.60)	(13.88)	(5.96)
	Cash flow	—	—	(36.47)	(39.81)	(22.71)	(11.14)	(14.03)	(10.44)	(8.49)	(4.11)
	Capex	—	—	(0.94)	(0.65)	(0.67)	(0.04)	(0.76)	(1.07)	(1.01)	0.00
	Free cash flow	—	—	(37.41)	(40.46)	(23.38)	(11.19)	(14.79)	(11.51)	(9.50)	(4.11)
	Book value	—	—	0.00	(136.54)	251.65	99.25	79.06	33.79	21.08	15.44
	Shares, m	—	—	2	2	5	13	14	14	15	16
Valuation, ×
Valuation, ×	P/E	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	—	—	0.00	0.00	10.23	6.07	2.79	1.59	0.43	0.32
	P/B	—	—	0.00	0.00	2.01	1.22	0.71	0.86	0.34	0.32
	EV/Sales	—	—	0.00	0.00	5.98	3.12	0.85	0.15	(0.47)	(0.42)
	EV/FCF	—	—	(5.92)	(5.92)	(12.66)	(5.55)	(1.16)	(0.25)	0.84	1.57
Cash, $m
Cash, $m	Operating cash flow	—	—	(74)	(82)	(112)	(142)	(192)	(148)	(127)	(66)
	Capex	—	—	(2)	(1)	(3)	(1)	(10)	(15)	(15)	0
	Free cash flow	—	—	(76)	(83)	(116)	(142)	(203)	(164)	(143)	(66)
Balance, $m
Balance, $m	Working capital	—	—	210	117	992	686	513	356	206	173
	Total debt	—	—	—	13	7	17	15	—	—	—
	Net debt	—	—	(261)	(178)	(1,043)	(746)	(539)	(372)	(228)	(182)
	Shareholders’ equity	—	—	—	(281)	1,246	1,261	1,084	480	316	248
Returns, %
Returns, %	ROA	—	—	0.00	(34.88)	(23.92)	(12.49)	(20.31)	(74.72)	(40.59)	(25.19)
	ROIC	—	—	0.00	0.00	(69.84)	(21.76)	(31.62)	(400.00)	(154.63)	(100.51)
	ROE	—	—	19.55	34.00	(46.50)	(14.07)	(23.07)	(86.34)	(52.27)	(33.93)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
CARL Carlsmed, Inc.	$380.9M	— (loss-making)	— (loss-making)	+56.75% (above 0%: growing)	n/m	−6.84% (below 0%: shrinking)	76.78%	(58.27%)	Compare
CSLT Castlight Health, inc.	$332.4M	— (loss-making)	— (loss-making)	−0.86% (below 0%: shrinking)	n/m	+106.49% (above 0%: growing)	66.20%	(5.42%)	Compare
SPOK Spok Holdings, Inc.	$224.5M	17.7×	16.2×	−1.89% (below 0%: shrinking)	−9.09% (below 0%: shrinking)	−2.00% (below 0%: shrinking)	80.47%	15.50%	Compare
AMWL American Well Corporation	$210.6M	— (loss-making)	— (loss-making)	−26.59% (below 0%: shrinking)	n/m	+266.38% (above 0%: growing)	52.95%	(18.36%)
SY So-Young International Inc. Sponsored ADR	$198.9M	— (loss-making)	12.8×	+40.84% (above 0%: growing)	n/m	−798.37% (below 0%: shrinking)	44.11%	(8.64%)	Compare
OPRX OptimizeRx Corp.	$166.7M	35.4×	23.0×	−29.77% (below 0%: shrinking)	n/m	+89.86% (above 0%: growing)	76.51%	(0.43%)	Compare
DH Definitive Healthcare Corp.	$144.3M	— (loss-making)	— (loss-making)	−9.14% (below 0%: shrinking)	n/m	+21.44% (above 0%: growing)	73.45%	(12.23%)	Compare
HCAT Health Catalyst, Inc.	$135.5M	— (loss-making)	— (loss-making)	−12.68% (below 0%: shrinking)	n/m	+64.26% (above 0%: growing)	49.46%	(51.75%)	Compare
LFMD LifeMD, Inc.	$118.6M	— (loss-making)	— (loss-making)	−3.55% (below 0%: shrinking)	n/m	−247.52% (below 0%: shrinking)	88.82%	(15.08%)	Compare
Median of peers	$182.8M	—	16.2×	−2.72%	—	+9.72%	74.98%	(10.43%)

All 51 Health Information Services stocks →

American Well Corporation (AMWL) key facts

Concern: American Well Corporation’s revenue for fiscal 2025 (year ended December 2025) was $249.3 million, down 1.98% from fiscal 2024.
Concern: American Well Corporation reported a net loss of $95.0 million, or a loss of $5.96 per share, for fiscal 2025.
American Well Corporation (AMWL) is a Health Information Services company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 16, 2026, AMWL traded at $11.68, a market capitalization of $210.6 million.
Trailing earnings are negative, so a P/E ratio is not meaningful; the stock trades at 0.9× sales.
Return on equity was −33.9% and debt-to-equity 0.00.
Its Piotroski F-score is 6 out of 9 and its Altman Z-score is −7.95 (distress zone) for fiscal 2025.